4//SEC Filing
Boyle Scott N 4
Accession 0001662579-23-000099
CIK 0001662579other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 7:23 PM ET
Size
5.3 KB
Accession
0001662579-23-000099
Insider Transaction Report
Form 4
Boyle Scott N
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-09-18+120,000→ 120,000 totalExercise: $2.15Exp: 2033-09-17→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]This option shall vest in full on September 18, 2025, subject to the Reporting Person's continued service on such date.
Documents
Issuer
C4 Therapeutics, Inc.
CIK 0001662579
Entity typeother
Related Parties
1- filerCIK 0001913897
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 7:23 PM ET
- Size
- 5.3 KB